Geode Capital Management, LLC Harrow Health, Inc. Transaction History
Geode Capital Management, LLC
- $1.39 Trillion
- Q2 2025
A detailed history of Geode Capital Management, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 810,803 shares of HROW stock, worth $27.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
810,803
Previous 774,079
4.74%
Holding current value
$27.9 Million
Previous $20.6 Million
20.26%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding HROW
# of Institutions
181Shares Held
21.4MCall Options Held
330KPut Options Held
670K-
Opaleye Management Inc. Boston, MA3.96MShares$136 Million28.93% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$74 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.89MShares$65.1 Million6.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$64.4 Million0.0% of portfolio
-
Braidwell LP Stamford, CT957KShares$32.9 Million1.56% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $932M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...